An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 508-514

  Lai, Tsung Hsuan ^a,b   Lee, Fa Kung ^a,c   Lin, Tseng Kai ^a,c   Horng, Shang Gwo ^a   Chen, Su Chee ^a,b   Chen, Ya Hui ^d   Wang, Pa Chun ^a,b,e  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d Cathay Medical Center   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

estradiol; gonadotropin releasing hormone agonist; IVF; ovarian reserve; pregnancy rate; Premature luteinization; progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; EVENING DOSAGE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEINIZATION; MAJOR CLINICAL STUDY; MORNING DOSAGE; OOCYTE RETRIEVAL; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREVALENCE; PROGESTERONE; PROGNOSIS; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 67651089929     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.036     Document Type: Article

References (47)

1. Younis J.S., Simon A., and Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril 66 (1996) 873-884
2. Edelstein M.C., Seltman H.J., Cox B.J., Robinson S.M., Shaw R.A., and Muasher S.J. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 54 (1990) 853-857
3. Schoolcraft W., Sinton E., Schlenker T., Huynh D., Hamilton F., and Meldrum D.R. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 55 (1991) 563-566
4. Silverberg K.M., Burns W.N., Olive D.L., Riehl R.M., and Schenken R.S. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 73 (1991) 797-803
5. Givens C.R., Schriock E.D., Dandekar P.V., and Martin M.C. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 62 (1994) 1011-1017
6. Hofmann G.E., Bentzien F., Bergh P.A., Garrisi G.J., Williams M.C., Guzman I., et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 60 (1993) 675-679
7. Legro R.S., Ary B.A., Paulson R.J., Stanczyk F.Z., and Sauer M.V. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod 8 (1993) 1506-1511
8. Yovel I., Yaron Y., Amit A., Peyser M.R., David M.P., Kogosowski A., et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril 64 (1995) 128-131
9. Hofmann G.E., Khoury J., Johnson C.A., Thie J., and Scott Jr. R.T. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 66 (1996) 980-986
10. Randall G.W., Gantt P.A., Gantt D., Kirk M.J., and Romines N. Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate down-regulated GIFT cycles are associated with decreased clinical pregnancy rates. J Assist Reprod Genet 13 (1996) 459-463
11. Shulman A., Ghetler Y., Beyth Y., and Ben-Nun I. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet 13 (1996) 207-211
12. Fanchin R., de Ziegler D., Taieb J., Hazout A., and Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 59 (1993) 1090-1094
13. Copperman A.B., Horowitz G.M., Kaplan P., Scott R.T., Navot D., and Hofmann G.E. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril 63 (1995) 1267-1271
14. Younis J.S., Matilsky M., Radin O., and Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 76 (2001) 294-299
15. Ubaldi F., Camus M., Smitz J., Bennink H.C., Van Steirteghem A., and Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 66 (1996) 275-280
16. Mio Y., Sekijima A., Iwabe T., Onohara Y., Harada T., and Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 58 (1992) 159-166
17. Abuzeid M.I., and Sasy M.A. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril 65 (1996) 981-985
18. Fanchin R., de Ziegler D., Castracane V.D., Taieb J., Olivennes F., and Frydman R. Physiopathology of premature progesterone elevation. Fertil Steril 64 (1995) 796-801
19. Fanchin R., Righini C., Olivennes F., Ferreira A.L., de Ziegler D., and Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril 68 (1997) 799-805
20. Younis J.S., Haddad S., Matilsky M., and Ben-Ami M. Premature luteinization: could it be an early manifestation of low ovarian reserve?. Fertil Steril 69 (1998) 461-465
21. Veeck L.L. Atlas of the human oocyte and early conception (1991), Williams & Wilkins, Baltimore
22. Chen M.J., and Bongso A. Comparative evaluation of two density gradient preparations for sperm separation for medically assisted conception. Hum Reprod 14 (1999) 759-764
23. Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 5 (1990) 357-376
24. Manzi D.L., Dumez S., Scott L.B., and Nulsen J.C. Selective use of leuprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fertil Steril 63 (1995) 866-873
25. Hamori M., Stuckensen J.A., Rumpf D., Kniewald T., Kniewald A., and Kurz C.S. Premature luteinization of follicles during ovarian stimulation for in-vitro fertilization. Hum Reprod 2 (1987) 639-643
26. Kagawa T., Yamano S., Nishida S., Murayama S., and Aono T. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET). J Assist Reprod Genet 9 (1992) 106-112
27. Harada T., Yoshida S., Katagiri C., Takao N., Ikenari T., Toda T., et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 10 (1995) 1060-1064
28. Bosch E., Valencia I., Escudero E., Crespo J., Simon C., Remohi J., et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 80 (2003) 1444-1449
29. Ozcakir H.T., Levi R., Tavmergen E., and Goker E.N. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. J Obstet Gynaecol Res 30 (2004) 100-104
30. Ezra Y., Simon A., Sherman Y., Benshushan A., Younis J.S., and Laufer N. The effect of progesterone administration in the follicular phase of an artificial cycle on endometrial morphology: a model of premature luteinization. Fertil Steril 62 (1994) 108-112
31. Fanchin R., Righini C., Olivennes F., de Ziegler D., Selva J., and Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 65 (1996) 1178-1183
32. Bustillo M., Stern J.J., and Coulam C.B. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod 10 (1995) 2862-2867
33. Ubaldi F., Smitz J., Wisanto A., Joris H., Schiettecatte J., Derde M.P., et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod 10 (1995) 3091-3096
34. Sharma V., Whitehead M., Mason B., Pryse-Davies J., Ryder T., Dowsett M., et al. Influence of superovulation on endometrial and embryonic development. Fertil Steril 53 (1990) 822-829
35. Howles C.M., Macnamee M.C., and Edwards R.G. Progesterone supplementation in the late follicular phase of an in-vitro fertilization cycle: a "natural" way to time oocyte recovery?. Hum Reprod 3 (1988) 409-412
36. Ben-Nun I., Ghetler Y., Jaffe R., Siegal A., Kaneti H., and Fejgin M. Effect of preovulatory progesterone administration on the endometrial maturation and implantation rate after in vitro fertilization and embryo transfer. Fertil Steril 53 (1990) 276-281
37. Hassiakos D., Toner J.P., Muasher S.J., and Jones Jr. H.W. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. Hum Reprod 5 (1990) 1004-1008
38. Nilsson O., Englund D., Weiner E., and Victor A. Endometrial effects of levonorgestrel and estradiol: a scanning electron microscopic study of the luminal epithelium. Contraception 22 (1980) 71-83
39. Gidley-Baird A.A., O'Neill C., Sinosich M.J., Porter R.N., Pike I.L., and Saunders D.M. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice. Fertil Steril 45 (1986) 69-74
40. Hadi F.H., Chantler E., Anderson E., Nicholson R., McClelland R.A., and Seif M.W. Ovulation induction and endometrial steroid receptors. Hum Reprod 9 (1994) 2405-2410
41. Valbuena D., Martin J., de Pablo J.L., Remohi J., Pellicer A., and Simon C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 76 (2001) 962-968
42. Testart J., Belaisch-Allart J., and Frydman R. Relationships between embryo transfer results and ovarian response and in vitro fertilization rate: analysis of 186 human pregnancies. Fertil Steril 45 (1986) 237-243
43. Stokman P.G., de Leeuw R., van den Wijngaard H.A., Kloosterboer H.J., Vemer H.M., and Sanders A.L. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 60 (1993) 175-178
44. Rodgers M., McLoughlin J., Peers N., Anderson J., Woods P., Mitchell G.G., et al. Accumulation of human chorionic gonadotrophin in the serum of patients during in-vitro fertilization treatment cycles with Pergonal. Hum Reprod 9 (1994) 638-642
45. Sengoku K., Tamate K., Takaoka Y., Morishita N., and Ishikawa M. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility. Hum Reprod 9 (1994) 1043-1047
46. Dumesic D.A. Periovulatory serum progesterone levels as a predictor of pregnancy outcome during ovarian hyperstimulation for assisted reproductive technology. Fertil Steril 62 (1994) 911-912
47. Melo M.A., Meseguer M., Garrido N., Bosch E., Pellicer A., and Remohi J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod 21 (2006) 1503-1507